|
"tsou hh"的相關文件
顯示項目 101-116 / 116 (共3頁)
<< < 1 2 3
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2011-05 |
Genetic polymorphisms of CYP2C19 associated with the side effect and serum concentrations of antidepressant paroxetine
|
Chan, HW;Tsou, HH;Tian, JN;Lin, KM;Hsiao, MC;Shen, WW;Lu, ML;Tang, HS;Fang, CK;Wu, CS;Lu, SC;Liu, SC;Chen, CY;Liu, YL |
| 國家衛生研究院 |
2011-05 |
Opioid receptor Mu1 genetic polymorphisms influence QT prolongation and insomnia in methadone maintenance patients
|
Tian, JN;Wang, SC;Ho, IK;Tsou, HH;Lin, KM;Hsiao, CF;Chen, CH;Tan, HKL;Lin, LN;Wu, CS;Su, LW;Huang, CL;Yang, YH;Liu, ML;Chen, CY;Liu, SC;Wu, HY;Kuo, HW;Liu, YL |
| 國家衛生研究院 |
2011-04 |
ABCB1 gene polymorphisms are associated with the severity of major depressive disorder and its response to escitalopram treatment
|
Lin, KM;Chiu, YF;Tsai, IJ;Chen, CH;Shen, WW;Liu, SC;Lu, SC;Liu, CY;Hsiao, MC;Tang, HS;Liu, SI;Chang, LH;Wu, CS;Tsou, HH;Tsai, MH;Chen, CY;Wang, SM;Kuo, HW;Hsu, YT;Liu, YL |
| 國家衛生研究院 |
2010-11 |
CYP1A2 genetic polymorphisms are associated with treatment response to the antidepressant paroxetine
|
Lin, KM;Tsou, HH;Tsai IJ;Hsiao, MC;Hsiao, CF;Liu CY;Shen, WW;Tang, HS;Fang, CK;Wu, CS;Lu, SC;Kuo, HW;Liu, SC;Chan, HW;Hsu, YT;Tian, JN;Liu, YL |
| 國家衛生研究院 |
2010-07 |
Proposals of statistical consideration to evaluation of results for a specific region in multi-regional trials - Asian perspective
|
Tsou, HH;Chow, SC;Lan, KK;Liu, JP;Wang, M;Chern, HD;Ho, LT;Hsiung, CA;Hsiao, CF |
| 國家衛生研究院 |
2010-07 |
Sample size determination for a specific region in a multiregional trial
|
Ko, FS;Tsou, HH;Liu, JP;Hsiao, CF |
| 國家衛生研究院 |
2010-05 |
Validation of the Chinese-Canadian study of health and aging clinical frailty scale (CSHA-CFS) telephone version
|
Chan, DC;Tsou, HH;Chen, CY |
| 國家衛生研究院 |
2009 |
Statistical validation of traditional Chinese diagnostic procedures
|
Hsiao, CF;Tsou, HH;Pong, A;Liu, JP;Lin, CH;Chang, YJ;Chow, SC |
| 國家衛生研究院 |
2009 |
Translation in clinical technology-traditional Chinese medicine
|
Hsiao, CF;Tsou, HH;Chow, SC |
| 國家衛生研究院 |
2008-12 |
Translation in different diagnostic procedures—traditional Chinese medicine and western medicine
|
Hsiao, CF;Tsou, HH;Wu, YJ;Lin, CH;Chang, YJ |
| 國家衛生研究院 |
2008 |
A two-stage design for drug screening trials based on continuous endpoints
|
Tsou, HH; Hsiao, CF; Chow, SC; Liu, JP |
| 國家衛生研究院 |
2008 |
Application of hierarchical models for detection of spatially clustered diseases in Taiwan
|
Chang, ML;Lin, PS;Tsou, HH |
| 國家衛生研究院 |
2007-01 |
Use of prior information for Bayesian evaluation of bridging studies
|
Hsiao, CF; Hsu, YY; Tsou, HH; Liu, JP |
| 國家衛生研究院 |
2007 |
Mixed noninferiority margin and statistical tests in active controlled trials
|
Tsou, HH; Hsiao, CF; Chow, SC; Yue, L; Xu, YL; Lee, SJ |
| 國家衛生研究院 |
2006-08 |
Impaired phagocytosis of capsular serotypes K1 or K2 Klebsiella pneumoniae in type 2 diabetes mellitus patients with poor glycemic control
|
Lin, JC; Siu, LK; Fung, CP; Tsou, HH; Wang, JJ; Chen, CT; Wang, SC; Chang, FY |
| 高雄醫學大學 |
2005 |
MCPT引起之內皮相關及不相關之血管鬆弛作用: 經由cyclic nucleotides;鉀通道打開;磷酸二酯酶抑制作用
|
羅怡卿;鄒惠霞;林榮峙;吳登強;吳炳男;林永哲;陳英俊 ; Lo YC;Tsou HH;Lin RJ;Wu DC;Wu BN;Lin YT;Chen IJ |
顯示項目 101-116 / 116 (共3頁)
<< < 1 2 3
每頁顯示[10|25|50]項目
|
